Table 1 Distribution of case controls by clinical characteristics
From: Case-control study of the characteristics and risk factors of hot clot artefacts on 18F-FDG PET/CT
Clinical characteristics | Cases (n = 211) | Controls (n = 422) | OR [95%CI] | p |
|---|---|---|---|---|
Sex | ||||
Male | 98 (46.5) | 194 (46.0) | 1.02 (0.73–1.43) | 0.910 |
Female | 113 (53.6) | 228 (54.0) | ||
Age (year) | 62.2 ± 15.4 | 65.9 ± 13.8 | 0.002 | |
Weight (Kg) | 69.8 ± 15.9 | 71.0 ± 16.8 | 0.374 | |
Blood glucose level (mmol/L) | 5.7 ± 1.0 | 5.8 ± 1.2 | 0.124 | |
Active cancer | ||||
Yes | 132 (62.6) | 275 (65.2) | 0.89 (0.63–1.27) | 0.519 |
No | 79 (37.4) | 147 (34.8) | ||
Anticoagulant treatment | ||||
Yes | 29 (13.7) | 51 (12.1) | 1.16 (0.70–1.89) | 0.773 |
No | 143 (67.8) | 297 (70.4) | ||
NA | 39 (18.5) | 74 (17.5) | ||
Antiplatelet drug | ||||
Yes | 34 (16.1) | 68 (16.1) | 1.00 (0.63–1.56) | 0.997 |
No | 139 (65.9) | 279 (66.1) | ||
NA | 38 (18.0) | 75 (17.8) | ||
Previous history of VTE | ||||
Yes | 11 (5.2) | 27 (6.4) | 0.81 (0.38–1.64) | 0.818 |
No | 162 (76.8) | 323 (76.5) | ||
NA | 38 (18.0) | 72 (17.1) | ||